Predicting Melanoma Patient Responses to Immunotherapies (IMAGE)

American Association for the Advancement of Science (AAAS)

Predicting Melanoma Patient Responses to Immunotherapies

Caption

Researchers identified a set of genetic changes that predict whether melanoma patients will respond to checkpoint inhibitor therapies.

Credit

Chris Bickel / <i>Science Translational Medicine</i> (2017)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.